Cover image of the article: Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV

Image Credit:Hepat Mon

Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV

Authors

Azita Ganji1,*, Abbas Esmaeilzadeh2, Kamran Ghafarzadegan2, Hoda Helalat2, Houshang Rafatpanah2, Ali Mokhtarifar2
1Department of Internal Medicine , Imam Reza Hospital, Mashhad University of Medical Sciences, Azita_ganji@yahoo.com, IR Iran
2Department of Internal Medicine , Imam Reza Hospital, Mashhad University of Medical Sciences, IR Iran
*Corresponding Author: Department of Internal Medicine , Imam Reza Hospital, Mashhad University of Medical Sciences, Azita_ganji@yahoo.com, IR Iran. Tel: +98-8598818. Fax: +98-8598818. Email: Azita_ganji@yahoo.com

Hepatitis Monthly:Vol. 11, issue 5; 342-345
Published online:May 31, 2011
Article type:Research Article
Received:Jun 16, 2010
Accepted:Jan 25, 2011
How to Cite:Ganji A, Esmaeilzadeh A, Ghafarzadegan K, Helalat H, Rafatpanah H, et al. Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV. Hepat Mon. 2011;11(5):. doi:

Abstract

Background: Viral load has been used to diagnose and monitor patients who are being treated for chronic hepatitis B (CHB). The Diagnosis methods are molecular-based and expensive. Quantitation of hepatitis B surface antigen (HBsAg) by automated chemiluminescent micro-particle immunoassay has been proposed to be a surrogate marker. Quantitating HBV DNA levels molecularly is expensive; thus, a cheaper laboratory test as a surrogate diagnostic marker might simplify our management.
Objectives:We determined whether quantitative HBsAg levels correlate with HBV DNA levels in CHB.
Patients and Methods: In this cross-sectional study, all CHB patients who were referred by a gastroenterologist to undergo quantitative HBV DNA assay in a qualified laboratory in Mashhad, Iran in 2009 were enrolled, and blood samples was obtained. Patients who were positive for antibodies to HCV and HDV were excluded. HBV DNA was measured by real-time polymerase chain reaction, and serum HBsAg was quantified byelectrochemiluminescence assay (Roche Diagnostic).
Results:Of 97 patients, 70 were male (72%) and 27 were female (28%); the mean age was 39 ± 11 years. Eighty-seven percent wasHBeAg-negative. By Mann-Whitney test,HBSAg titer differed significantly between HBeAg-positive and -negative patients (P = 0.001), as did HBV DNA levels (P = 0.009). By Spearman test, there was no significant correlation between HBsAg and HBV DNA levels (P= 0.606 and r = 0.53).
Conclusions:HBeAg-negative patients have higher levels of HBsAg and lower levels of HBV DNA. By electrochemiluminescence assay,HBsAg has no significant correlation with HBV DNA levels in CHB with predominant genotype D and HBeAg negativity in Iran.


Implication for health policy/practice/research/medical education:
Quantitative detection of HBsAg as one of the new diagnostic methods is discussed recently in many papers. This article opens new windows toward basic scientists, clinicians in the field of hepatology and infection diseases.
Please cite this paper as:
Ganji A, Esmaeilzadeh A, Ghafarzadegan K, Helalat H, Rafatpanah H, Mokhtarifar A. Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV. Hepat Mon.2011;11(5):342-345.

Copyright 2011, BRCGL, Published by Kowsar M.P.Co All right reserved.


Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

8
Mar
2017
Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection

Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection

Ergenekon Karagoz,
Alpaslan Tanoglu

Karagoz E, Tanoglu A. Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection. Hepat Mon. 2017;17(4):e12293. doi: https://doi.org/10.5812/hepatmon.36112

23
Sep
2017
Correlation of Quantitative Assay of HBsAg and Hepatitis B Virus DNA Levels Among Chronic HBV Patients Attending Pathologist Lancet Laboratory in Nairobi, Kenya

Correlation of Quantitative Assay of HBsAg and Hepatitis B Virus DNA Levels Among Chronic HBV Patients Attending Pathologist Lancet Laboratory in Nairobi, Kenya

Faith Mathai,
Musa Otieno Ngayo,
Simon Muturi Karanja,
Ahmed Kalebi,
Raphael Lihana

Mathai F, Otieno Ngayo M, Muturi Karanja S, Kalebi A, Lihana R. Correlation of Quantitative Assay of HBsAg and Hepatitis B Virus DNA Levels Among Chronic HBV Patients Attending Pathologist Lancet Laboratory in Nairobi, Kenya. Arch Clin Infect Dis. 2017;12(4):e13306. doi: https://doi.org/10.5812/archcid.13306

29
Feb
2016
Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes

Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes

Claudia Minosse,
Sabrina Coen,
Ubaldo Visco Comandini,
Raffaella Lionetti,
Marzia Montalbano,
Stefano Cerilli
,et al.

Minosse C, Coen S, Visco Comandini U, Lionetti R, Montalbano M, et al. Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes. Hepat Mon. 2016;16(10):e28751. doi: https://doi.org/10.5812/hepatmon.28751

31
Dec
2005
HBV DNA Viral Load and Chronic Hepatitis Infection in Different Stages

HBV DNA Viral Load and Chronic Hepatitis Infection in Different Stages

Bita Behnava,
Shervin Assari,
Mohsen Amini,
Bashir Hajibeigi,
Hassan Manzouri Jouybari,
Seyed Moayed Alavian

Behnava B, Assari S, Amini M, Hajibeigi B, Jouybari H, et al. HBV DNA Viral Load and Chronic Hepatitis Infection in Different Stages. Hepat Mon. 2005;5(4):. doi:

31
May
2011
The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers

The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers

Eun Sun Kim,
Yeon Seok Seo,
Bora Keum,
Ji Hoon Kim,
Hyonggin An,
Hyung Joon Yim
,et al.

Kim E, Seo Y, Keum B, Kim J, An H, et al. The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers. Hepat Mon. 2011;11(5):. doi:

More by these authors

Azita GanjiPubMedScholar
Abbas EsmaeilzadehPubMedScholar
Kamran GhafarzadeganPubMedScholar
Hoda HelalatPubMedScholar
Houshang RafatpanahPubMedScholar
Ali MokhtarifarPubMedScholar
Share
Cited by
Metrics